Table 4 Univariate and multivariate analysis of postoperative severe complications
From: Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma
Variables | No complications | Complications | Univariate analysis | Multivariate analysis | |
|---|---|---|---|---|---|
251 | 29 | P | OR (95% CI) | P | |
Gender | 217/34 | 21/8 | 0.045 | Â | Â |
Age (year) (≤ 50 vs > 50) | 117/134 | 14/15 | 0.865 |  |  |
Diabetes (yes vs no) | 19/232 | 3/26 | 0.486 | Â | Â |
Hypertension (yes vs no) | 46/205 | 7/22 | 0.449 | Â | Â |
ASA grading (≤ 2 vs > 2) | 178/73 | 17/12 | 0.173 |  |  |
Total bilirubin (μmol/L) | 20.6 ± 33.5 | 57.6 ± 97.3 | 0.052 |  |  |
Albumin (g/L) | 39.4 ± 5.6 | 36.9 ± 4.1 | 0.021 |  |  |
ALT (U/L) | 48.8 ± 42.8 | 100.6 ± 116.6 | 0.024 | 1.006 (1.001–1.011) | 0.019 |
AST (U/L) | 51.1 ± 52.7 | 106.2 ± 110.6 | 0.013 |  |  |
GP73 (≤ 79.2 vs > 79.2 ng/mL) | 151/100 | 5/24 | < 0.001 | 4.970 (1.654–14.934) | 0.004 |
Size of tumor (cm) | 6.1 ± 3.5 | 7.3 ± 4.5 | 0.065 |  |  |
Number of tumors | 1.2 ± 0.5 | 1.1 ± 0.4 | 0.785 |  |  |
Operation time (min) | 230.0 ± 208.7 | 263.8 ± 98.6 | 0.390 |  |  |
Blood loss (mL) | 705.3 ± 789.9 | 1669.0 ± 1662.6 | 0.004 | 1.001 (1.000–1.001) | < 0.001 |
Intraoperative RBC transfusion | 2.5 ± 2.9 | 6.0 ± 6.5 | < 0.001 |  |  |